triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial Today, we shared new data from two 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio retatrutide obesity triple hormone receptor
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
























